Article Details
Retrieved on: 2020-12-08 11:39:47
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Xencor, which is focused on developing engineered <b>monoclonal antibodies</b> for the treatment of cancer and autoimmune diseases, will receive $50 ...
Article found on: labusinessjournal.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here